'Lalaola' wins 2024 Pharma Industry ad grand prize

Dailypharm hosted the 12th '2024 Korean Pharmaceutical & Biotech Industry Advertising·PR Awards Ceremony'

66 contents were submitted to the advertising·PR categories…17 contents won prizes

Grand prizes were presented to Yuhan's 'Lalaola' in the advertising category·Amgen Korea's 'Blue Wish campaign' in the PR category

The winner of the 2024 pharmaceutical and biotechnology industry advertising·PR awards has been announced.

 

Yuhan's 'Lalaola' won the Grand Prize in the advertising category, and Amgen Korea's 'Blue Wish campaign' won the Grand Prize in the PR category.

 

On December 10, Dailypharm (Publisher: Lee Jeong Seok) hosted the '2024 Korean Pharmaceutical & Biotech Industry Advertising·PR Awards Ceremony' at the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA)'s K-Room.

 

This year, the awards ceremony marked 12 years, and 66 contents in the advertising and PR categories were submitted to compete.

 

On December 10, Dailypharm (Publisher: Lee Jeong Seok) hosted the 12th

The awards were categorized into the advertising and PR sectors.

 

In the advertising category, a grand prize, three best prizes, and seven excellence awards have been selected.

 

In the PR category a grand prize, two best prizes, and three excellence awards have been awarded.

 

The awards were presented in the advertising category by the following sections: ▲TV·CF ▲Prints·Radio▲Internet·SNS, in the PR category: ▲Social Contribution·Disease Awareness Campaigns ▲Corporate·Product Promotion.

 

Yuhan's 'Lalaola' won the Grand Prize in the advertising cateogry.

 

The winner was presented with a plaque and a cash prize of KRW 5 million.

 

Yuhan won the Grand Prize in the advertising category.

The award recipient Kim Jong-won, Director of External Affairs at Yuhan, stated, "Lalaola was launched in South Korea in July 2023, and this year, we have made efforts to promote the product.

 

We hope Lalaola will grow in the market for high-dose arginine, similar to Mag-B.

 

We look forward to participating in the ceremony next year again." In the TV·CF category, Johnson & Johnson Korea's 'Tylenol' and Iksu Pharmaceutical's 'Iksu Kongjin-dan' were awarded the best prize, receiving plaques and a cash prize of KRW 3 million.

 

Handok's 'Ketotop,' Chong Kun Dang's 'Braining Cap,' Reckitt Korea's 'Gaviscon,' and Daewon Pharm's 'Coldaewon Kids' won the excellence awards.

 

In the Internet·SNS category, Jeil Health Science's 'Jeil Cool Pap' was awarded the best price.

 

Excellence awards were given to Dongkook Pharmaceutical's 'Cencia' and Kyung Nam Pharm's 'PM-Zol-Q series,' each receiving trophies and a cash prize of KRW 2 million.

 

Dongsung Bio Pharm's 'Loxo-N Gel' won the excellence award in the Prints·Radio category.

 

In the PR category, entries that delivered meaningful messages to society, particularly those focusing on social contributions and ESG activities, were awarded.

 

This year's grand prize in the PR category went to Amgen Korea's 'Blue Wish campaign,' a social contribution initiative fulfilling the wishes of children with rare diseases.

 

The award included a plaque and a cash prize of KRW 5 million.

 

Seohyun Kim, Director of External Affairs at Amgen Korea, said, "We are pleased to receive such an honorable award.

 

Three weeks ago, we decorated a room for a child who has been battling leukemia for a long time.

 

The child's dream was to have a newly decorated room, and fulfilling that dream was deeply moving.

 

I'll be joining the volunteers tonight, and I intend to dedicate this award to them.

 

I will also donate the prize money." In the PR subcategory for Social Contribution·Disease Awareness Campaigns, the best awards went to Novartis Korea's 'Shine a Light on HS (Hidradenitis Suppurativa)' campaign.

 

Sanofi's 'Helping Hands' campaign received the excellence award.

 

In the Corporate·Product Promotion category, the best prize was awarded to HK Inno.

 

N's corporate promotion program, which received a plaque and a cash prize of KRW 3 million.

 

JW Pharmaceutical's 'JW R&D Insight' and Shinshin Pharmaceutical's 'Short Form' campaign won excellence awards.

 

Korean Pharmaceutical & Biotech Industry Advertising·PR Awards were established in 2013 to encourage advertising and PR professionals who bring new value to the pharmaceutical industry and medicines and promote the creation of advertisements that resonate with pharmacists, the primary target of pharmaceutical advertising.

 

In his opening remarks, In-ho Ga, Head of the Dailypharm's Press Department, stated, "I believe the fresh and creative ideas of advertising and PR professionals have made significant contributions to pharmaceutical branding.

 

I sincerely congratulate the winning companies." This year's contest was judged by a panel led by Daechun Ahn, the former President of the Korean Advertising Society (Professor at Korea University), along with Jae Hoon Cheong, Professor at Sahmyook University College of Pharmacy, and Jae-Kook Lee, Senior Vice President of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA).

 

"We evaluated whether the strategy and messaging were clear and effectively conveyed in the advertising category.

 

In the PR category, we focused on the campaigns' authenticity, consistency, and sustainability.

 

Many excellent works that met the judging criteria were submitted," Ahn explained.

 

"This event is meaningful in recognizing the hard work of advertising and PR professionals in the pharmaceutical and biotech industry over the past year.

 

Next year, many PR professionals are expected to continue to play a pivotal role," Jae-Kook Lee, Senior Vice President of KPBMA remarked.

 

Youngshin Lee, the CEO of the Korean Research-Based Pharma Industry Association (KRPIA), said in a video message, "The importance of precise pharmaceutical information has been emphasized, and the media environment is changing.

 

Delivering accurate medication information is essential for helping patients and their families return to their daily routines.

 

I extend my gratitude and encouragement to the advertising and PR professionals who design sincere campaigns to promote pharmaceuticals.

 

I hope this advertising award acts as a meaningful platform that enhances the pride of PR professionals in the industry."